Abstract
Several recent studies have tried to characterize the effects of a lower-than-usual target blood pressure on progression of nondiabetic kidney disease. An observational study, the Modification of Diet in Renal Disease Study, showed long-term benefit. The randomized African-American Study of Kidney Disease and Hypertension showed no benefit, nor did the recently published Ramipril Efficacy in Nephropathy 2 Trial. Here's our take on these conflicting study results.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 79-81 |
| Number of pages | 3 |
| Journal | Annals of internal medicine |
| Volume | 143 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 5 2005 |
| Externally published | Yes |
ASJC Scopus subject areas
- Internal Medicine